All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@bbcnews's testosterone and singing claims, fact-checked

BBC News

TikTok creator

24.9K viewsWatch on TikTok→

Quick answer

Testosterone therapy in trans men produces irreversible vocal pitch lowering, typically beginning within 3 to 6 months of initiation, with a variable mutation period that can temporarily impair singing range and control. For professional voice users, WPATH Standards of Care Version 8 recommends concurrent voice therapy throughout the transition period. Outcomes vary significantly by individual, and complete restoration of pre-transition singing ability in the same register is not a reliable expectation.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @bbcnews actually say?

Teddy Hines, a trans man and musical theatre performer, documented his voice changing on testosterone (T). He acknowledged upfront that T "would affect my job for a while" and that choosing to transition "far, far outweighed my career." He also described using video recordings at one day and five months on T to track progress and manage gender dysphoria. No miracle claims. No promise that his career would be unaffected. That honesty matters.

What the video does not do is make specific medical claims about testosterone therapy outcomes. It is a personal account, not a how-to guide. The BBC framing positions it as a human interest story about a performer managing voice change during transition, which is a real and documented clinical challenge.

Does the science back this up?

Yes, substantially. Testosterone does cause vocal changes in trans men, and those changes are real, sometimes career-disrupting, and not fully predictable. The research here is actually fairly consistent, which is unusual in gender medicine.

A 2017 study by Damrose in the journal Journal of Voice found that testosterone therapy in trans men lowers fundamental frequency (pitch) significantly, typically within 3 to 6 months of starting treatment. A broader systematic review by Azul et al. (2017, International Journal of Language and Communication Disorders) confirmed that vocal changes vary widely between individuals and that some trans men experience incomplete masculinization of the voice even after years on T.

For singers specifically, the challenge is more complex. A 2019 paper by Kenny and Wyatt in Logopedics Phoniatrics Vocology noted that trained singers on testosterone face a period of vocal instability analogous to adolescent voice mutation, during which range, control, and stamina can all suffer temporarily. Most singers, with appropriate voice therapy, do regain functional singing ability, though the register and range shift permanently.

Teddy's framing of this as a temporary disruption rather than a permanent career-ender lines up with what the literature actually shows.

What did they get wrong (or right)?

Mostly right, with one gap worth naming. Teddy got the emotional and practical reality correct: testosterone does disrupt a singer's voice, the timeline is uncertain, and tracking progress over months is genuinely useful for managing dysphoria. Give him credit for not overpromising.

The gap is context he did not provide, which is fair since this is a 60-second TikTok, not a clinical explainer. Viewers watching this might assume that all trans men on T will eventually sing again without significant limitation. That is not guaranteed. Azul et al. (2017) specifically cautioned that vocal outcomes on testosterone are heterogeneous. Some singers experience permanent loss of upper register notes. Others find their new vocal range opens up new repertoire. It depends on baseline anatomy, dose, duration, and whether voice therapy is used alongside hormone therapy.

The BBC also did not contextualize the role of a voice therapist, which is the standard of care recommendation from the World Professional Association for Transgender Health (WPATH Standards of Care, Version 8, 2022) for trans men who are professional voice users.

What should you actually know?

If you are a trans man on T, or considering it, and your voice is central to your work or identity, here is what the evidence says without the feel-good gloss.

  • Vocal pitch lowering typically begins within 3 to 6 months and is considered irreversible once it occurs (Damrose, 2017).
  • The mutation period, during which your voice may crack, lose range, and feel unreliable, can last 12 to 24 months according to clinical experience reported in WPATH SOC8.
  • Working with a voice therapist who has experience with trans patients is associated with better outcomes for professional voice users. This is not optional for singers; it is the standard recommendation.
  • Testosterone dose and formulation affect the rate but not necessarily the final outcome of vocal change. Faster is not better for singers.
  • Comparing recordings over time, exactly what Teddy describes doing, is a validated psychological tool. Research on minority stress and transition-related dysphoria (Testa et al., 2015, Psychology of Sexual Orientation and Gender Diversity) supports using concrete progress markers to buffer dysphoria during difficult transition periods.

Teddy's story is real and his approach is reasonable. But one performer's positive trajectory should not be read as a guarantee for everyone starting T.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @bbcnews's testosterone and singing claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@bbcnews's testosterone and singing claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Testosterone therapy in trans men produces irreversible vocal pitch lowering, typically beginning within 3 to 6 months of initiation, with a variable mutation period that can temporarily impair singing range and control.

FormBlends verdict

Testosterone therapy in trans men produces irreversible vocal pitch lowering, typically beginning within 3 to 6 months of initiation, with a variable mutation period that can temporarily impair singing range and control. For professional voice users, WPATH Standards of Care Version 8 recommends concurrent voice therapy throughout the transition period. Outcomes vary significantly by individual, and complete restoration of pre-transition singing ability in the same register is not a reliable expectation.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone therapy in trans men produces irreversible vocal pitch lowering, typically beginning within 3 to 6 months of initiation, with a variable mutation period that can temporarily impair singing range and control. For professional voice users, WPATH Standards of Care Version 8 recommends concurrent voice therapy throughout the transition period. Outcomes vary significantly by individual, and complete restoration of pre-transition singing ability in the same register is not a reliable expectation.
  • Testosterone lowers fundamental vocal frequency in trans men, typically beginning within 3 to 6 months; this change is considered irreversible once established (Damrose, 2017, Journal of Voice).
  • The vocal mutation period can last 12 to 24 months and may involve cracking, range loss, and reduced stamina, closely paralleling adolescent male voice change.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone lowers fundamental vocal frequency in trans men, typically beginning within 3 to 6 months; this change is considered irreversible once established (Damrose, 2017, Journal of Voice).
  • The vocal mutation period can last 12 to 24 months and may involve cracking, range loss, and reduced stamina, closely paralleling adolescent male voice change.
  • WPATH Standards of Care Version 8 (2022) specifically recommends voice therapy for trans men who are professional voice users, including singers, throughout the hormone transition period.
  • Vocal outcomes on testosterone vary significantly between individuals; some singers regain most of their functional range, others experience permanent loss of upper register notes (Azul et al., 2017).
  • Testosterone dose and delivery method influence the speed of vocal change but do not reliably determine the final outcome, so faster masculinization is not necessarily better for singers.
  • Using recordings to track voice change over time is both clinically observable and psychologically beneficial; progress monitoring is a documented coping tool for managing transition-related dysphoria (Testa et al., 2015).
  • One performer's positive outcome is not a clinical prediction. Trans men considering T who depend on their voice professionally should discuss timing, monitoring, and voice therapy with both an endocrinologist and a speech-language pathologist before and during treatment.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

BBC News · TikTok creator

24.9K views on this video

Musical theatre performer Teddy is taking #testosterone to help him transition - and he shows it won't stop him singing. #Trans #TransMan #MusicalTheater #Singer #BBCNews

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by BBC News, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.